More than 6 million people in the U.S. live with Alzheimer's disease. By 2050, it's projected to be 13 million people. Finding the proper treatment is crucial, but having access to earlier diagnostic tests can help change Alzheimer’s patients' future.
We look forward to seeing you at the AAN 2023 Annual Meeting in Boston, Mass., and exploring the future of Alzheimer’s research.
April 25, 2023
6:00-9:00 p.m. EST
Marquee Room, Omni Seaport Boston Hotel
Join us for an engaging symposium, where Dr. Apostolova and Dr. Sabbagh will discuss Alzheimer’s fluid biomarkers and highlight their role in the patient pathway. This program will provide a variety of clinical cases to highlight the utility of Alzheimer’s biomarkers. A Q&A session will conclude the program.